ADAGE CAPITAL PARTNERS GP, L.L.C.
Position in FULC — Fulcrum Therapeutics, Inc.
CIK 1165408
Boston, MA
Position in FULC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,068,000
-$16,159,000 QoQ
Shares Held
400,000
-76.5% QoQ
Ownership
0.600%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 168 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,579,664,431 across 120 Biotechnology names. FULC ranks #98 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,475,611 | $532,503,169 | |
| 2 | RPRX |
Royalty Pharma plc
|
7,480,633 | $358,845,965 | |
| 3 | CNTA |
Centessa Pharmaceuticals plc
|
8,925,010 | $354,501,397 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
12,794,097 | $354,396,486 | |
| 5 | TNGX |
Tango Therapeutics, Inc.
|
12,809,485 | $267,974,426 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
815,739 | $262,822,948 | |
| 7 | INSM |
INSMED Inc
|
900,000 | $147,168,000 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
737,578 | $124,665,433 |
All Filings in FULC
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,068,000 | 400,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,227,000 | 1,700,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $22,374,400 | 2,432,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $31,572,320 | 4,589,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,640,000 | 3,000,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $14,100,000 | 3,000,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,140,000 | 2,000,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,860,000 | 300,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,444,623 | 1,106,422 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $10,168,348 | 1,506,422 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,684,513 | 2,406,422 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,611,192 | 2,306,422 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $5,148,302 | 1,806,422 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,153,600 | 1,120,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,678,800 | 1,320,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,323,000 | 270,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $46,117,500 | 1,950,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $30,426,800 | 1,720,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $33,287,800 | 1,180,000 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||